Additionally, using integrated methods like The Cancer Genome Atlas Network (TCGA) provides a comprehensive understanding of the dynamics of TP53 mutations in a variety of cancer types, making it easier to identify new therapeutic targets and prognostic markers that will enhance patient outcomes and clinical management. The gene discussed is TP53; the disease is cancer.